Literature DB >> 12203213

Expression of CD10 by stromal cells during colorectal tumor development.

Hitoshi Ogawa1, Keiichi Iwaya, Miki Izumi, Masahiko Kuroda, Hiromi Serizawa, Yasuhisa Koyanagi, Kiyoshi Mukai.   

Abstract

CD10 is a cell surface metalloprotease expressed by a variety of normal cell types, including lymphoid precursor cells, germinal center B lymphocytes, and some epithelial cells. We noticed that stromal cells of some cancers are positive for CD10. In this study, we investigated the role of CD10 produced by the stromal cells of colorectal neoplasms in the progression of colorectal neoplasms. Immunohistochemical examination of CD10 and p53 was performed in 169 colorectal epithelial neoplasms representing various stages of carcinogenesis. The results were correlated with the morphologic characteristics of the neoplasms. There was no expression of CD10 in the stromal cells of normal colorectal tissue. CD10-positive stromal cells were present adjacent to the tumor cells in 16 of 73 adenomas with mild or moderate dysplasia. More frequent expression of CD10 by the stromal cells was detected in adenomas with severe dysplasia (12 of 17), intramucosal carcinomas (10 of 16), and invasive carcinomas (50 of 63) than in adenomas with mild or moderate dysplasia (P < 0.0001). Expression of CD10 by > 10% of the stromal cells was detected only within the area of the invasive growth front of invasive carcinomas, not in adenomas and in only 1 of the intramucosal carcinomas. The difference between invasive and non invasive tumors was significant (P < 0.0001). The stromal expression of CD10 was significantly associated with the accumulation of p53 and a larger tumor size. These results indicate that CD10 expression is an integral part of colorectal carcinogenesis. CD10 expression seems to contribute to the invasion and thus probably facilitates metastasis. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203213     DOI: 10.1053/hupa.2002.125773

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  31 in total

1.  EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.

Authors:  Azza Abdel-Aziz; Maha M Amin
Journal:  Diagn Pathol       Date:  2012-02-02       Impact factor: 2.644

2.  The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development.

Authors:  Tae Jung Jang; Jeong Bae Park; Jong Im Lee
Journal:  Korean J Pathol       Date:  2013-08-26

3.  Epithelial tumor, invasion and stroma.

Authors:  Masutaka Furue
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

4.  Comparision of Immunohistochemical Expression of CD10 in Odontogenic Cysts.

Authors:  Deepa K; M S Munisekhar; Charu Suri; Santosh Kumar Rajalbandi; Pradeep M R; Pavan Gothe
Journal:  J Clin Diagn Res       Date:  2014-11-20

5.  A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.

Authors:  G Haase; N Gavert; T Brabletz; A Ben-Ze'ev
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

6.  CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.

Authors:  Duygu Gürel; Aydanur Kargı; Ilgın Karaman; Ahmet Onen; Mehtat Unlü
Journal:  Pathol Oncol Res       Date:  2011-06-18       Impact factor: 3.201

7.  Epithelial to mesenchymal transition in cutaneous squamous cell carcinoma is correlated with COX-2 expression but not with the presence of stromal macrophages or CD10-expressing cells.

Authors:  Tae Jung Jang
Journal:  Virchows Arch       Date:  2012-03-30       Impact factor: 4.064

Review 8.  The role of the stroma in carcinogenesis.

Authors:  Nurija Bilalović; Semir Vranić; Fadila Serdarević; Faris Foco
Journal:  Bosn J Basic Med Sci       Date:  2006-02       Impact factor: 3.363

9.  Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.

Authors:  Lin Cui; Kenoki Ohuchida; Kazuhiro Mizumoto; Taiki Moriyama; Manabu Onimaru; Kohei Nakata; Toshinaga Nabae; Takashi Ueki; Norihiro Sato; Yohei Tominaga; Masao Tanaka
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

10.  CD10 expression in urothelial carcinoma of the bladder.

Authors:  Burak Bahadir; Kemal Behzatoglu; Sibel Bektas; Erol R Bozkurt; Sukru O Ozdamar
Journal:  Diagn Pathol       Date:  2009-11-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.